Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S D Katz

Showing results (1-10 of 58) with videos related to

Pageof 6
Sort By:
Journal of Cardiovascular Risk|April 1, 1995
Left ventricular thrombus and the incidence of thromboembolism in patients with congestive heart failure: can clinical factors identify patients at increased risk?S D Katz
Congestive Heart Failure (Greenwich, Conn.)|January 31, 2003
Potential role of type 5 phosphodiesterase inhibition in the treatment of congestive heart failureS D Katz
Congestive Heart Failure (Greenwich, Conn.)|February 6, 2002
Nesiritide (hBNP): a new class of therapeutic peptide for the treatment of decompensated congestive heart failureS D Katz
Progress in Cardiovascular Diseases|July 1, 1995
The role of endothelium-derived vasoactive substances in the pathophysiology of exercise intolerance in patients with congestive heart failureS D Katz
Current Opinion in Cardiology|May 1, 1997
Mechanisms and implications of endothelial dysfunction in congestive heart failureS D Katz
Physical Review Letters|May 1, 2001
Grand unification signal from ultrahigh energy cosmic rays?Z Fodor, S D Katz
The American Journal of Cardiology|February 19, 1998
Effect of endothelin-1 on exercise-induced vasodilation in normal subjects and in patients with heart failureH Krum, S D Katz
Drugs & Aging|April 16, 1998
Calcium sensitising agents in heart failureL Mathew, S D Katz
The American Journal of Cardiology|May 12, 2001
Acetylcholine-mediated vasodilation in the forearm circulation of patients with heart failure: indirect evidence for the role of endothelium-derived hyperpolarizing factorS D Katz, H Krum
Circulation|November 28, 2001
Sympathetic activation by sildenafilS D Katz, D V Parums
Pageof 6

Showing results (1-10 of 58) with videos related to

Sort By:
Pageof 6
Journal of Cardiovascular Risk|April 1, 1995
Left ventricular thrombus and the incidence of thromboembolism in patients with congestive heart failure: can clinical factors identify patients at increased risk?S D Katz
Congestive Heart Failure (Greenwich, Conn.)|January 31, 2003
Potential role of type 5 phosphodiesterase inhibition in the treatment of congestive heart failureS D Katz
Congestive Heart Failure (Greenwich, Conn.)|February 6, 2002
Nesiritide (hBNP): a new class of therapeutic peptide for the treatment of decompensated congestive heart failureS D Katz
Progress in Cardiovascular Diseases|July 1, 1995
The role of endothelium-derived vasoactive substances in the pathophysiology of exercise intolerance in patients with congestive heart failureS D Katz
Current Opinion in Cardiology|May 1, 1997
Mechanisms and implications of endothelial dysfunction in congestive heart failureS D Katz
Physical Review Letters|May 1, 2001
Grand unification signal from ultrahigh energy cosmic rays?Z Fodor, S D Katz
The American Journal of Cardiology|February 19, 1998
Effect of endothelin-1 on exercise-induced vasodilation in normal subjects and in patients with heart failureH Krum, S D Katz
Drugs & Aging|April 16, 1998
Calcium sensitising agents in heart failureL Mathew, S D Katz
The American Journal of Cardiology|May 12, 2001
Acetylcholine-mediated vasodilation in the forearm circulation of patients with heart failure: indirect evidence for the role of endothelium-derived hyperpolarizing factorS D Katz, H Krum
Circulation|November 28, 2001
Sympathetic activation by sildenafilS D Katz, D V Parums
Pageof 6